miRNA-338 could modulate pulmonary-hypertension-associated endothelial dysfunction with implications for pulmonary vascular and respiratory function through directly binding to the 3′-UTR of the HIF-1α mRNA, which causes abnormal ET-1 expression [17]. Here, HIF1A is linked to pulmonary arterial hypertension.